Co-occurring genomic alterations in non-small-cell lung cancer biology and therapy

$ 27.99

4.7
(119)
In stock
Description

Cells, Free Full-Text

Prognostic role of multiple abnormal genes in non-small-cell lung cancer

Frontiers Metabolic barriers in non-small cell lung cancer with LKB1 and/or KEAP1 mutations for immunotherapeutic strategies

Frontiers Characterization With KRAS Mutant Is a Critical Determinant in Immunotherapy and Other Multiple Therapies for Non-Small Cell Lung Cancer

JCM, Free Full-Text

IJMS, Free Full-Text

Comprehensive molecular profiling of lung adenocarcinoma

Therapeutic strategies for non-small cell lung cancer: Experimental models and emerging biomarkers to monitor drug efficacies - ScienceDirect

Co-occurring genomic alterations in non-small-cell lung cancer biology and therapy

Co-occurring genomic alterations in non-small-cell lung cancer biology and therapy

Frontiers Genomic landscape and efficacy of HER2-targeted therapy in patients with HER2-mutant non-small cell lung cancer